Search results
Be Bio’s haemophilia B treatment gains FDA orphan drug status
Pharmaceutical Technology via Yahoo Finance· 52 minutes agoThe US Food and Drug Administration (FDA) has granted orphan drug designation to Be Biopharma’s (Be...
MDMA therapy wait goes on as FDA panel rejects Lykos’ PTSD treatment
Pharmaceutical Technology via Yahoo Finance· 52 minutes agoA US Food and Drug Administration (FDA) panel has voted to decline approval of Lykos Therapeutics's...
FDA advisers vote against recommending approval of MDMA as treatment for PTSD
ABC News via Yahoo News· 13 hours agoA panel of independent advisers for the U.S. Food and Drug Administration voted against recommending...
Advisers to the U.S. Food And Drug Administration voted against the use of the psychedelic drug MDMA...
The Brunswick News· 9 hours agoAdvisers to the U.S. Food And Drug Administration voted against the use of the psychedelic drug MDMA...
US health experts vote against MDMA as treatment for PTSD
AFP via Yahoo News· 12 hours agoA panel of US health experts convened by the Food and Drug Administration on Tuesday overwhelmingly...
Post-traumatic stress disorder: What to know as FDA weighs MDMA therapy
Washington Post· 5 hours agoThe U.S. Food and Drug Administration is deciding whether MDMA, a mind-altering compound better...
FDA panel votes against ecstasy for PTSD
Axios· 14 hours agoA Food and Drug Administration advisory panel on Tuesday overwhelmingly recommended against using the drug ecstasy ...
Evolution Optiks secures 510(k) clearance for new eye examination device
Medical Device Network via Yahoo Finance· 3 hours agoLight field technology company Evolution Optiks has secured 510(k) clearance from the US Food and ...
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
Medical Xpress· 3 hours agoA panel of advisers to the Food and Drug Administration voted 10-1 against the overall benefits of...
F.D.A. Panel Rejects MDMA-Aided Therapy for PTSD
New York Times· 14 hours agoAn independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress...